O‐linked β‐N‐acetylglucosamine (O‐<scp>GlcNAc</scp>) modification: Emerging pathogenesis and a therapeutic target of diabetic nephropathyBingxue Qi, Li Kang|Diabetic Medicine|2024Cited by 19
Elevated RHAMM as a biomarker for predicting diabetic kidney disease in patients with type 2 diabetesBingxue Qi, Li-Hao Huang|Clinical Kidney Journal|2024Cited by 2